- Home
- CHRS vs VPV Comparison
CHRS vs VPV Comparison
Compare CHRS & VPV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHRS
- VPV
- Stock Information
- Founded
- CHRS 2010
- VPV 1993
- Country
- CHRS United States
- VPV United States
- Employees
- CHRS N/A
- VPV N/A
- Industry
- CHRS Biotechnology: Biological Products (No Diagnostic Substances)
- VPV Trusts Except Educational Religious and Charitable
- Sector
- CHRS Health Care
- VPV Finance
- Exchange
- CHRS Nasdaq
- VPV Nasdaq
- Market Cap
- CHRS 84.2M
- VPV 176.6M
- IPO Year
- CHRS 2014
- VPV N/A
- Fundamental
- Price
- CHRS $0.83
- VPV $10.09
- Analyst Decision
- CHRS Buy
- VPV
- Analyst Count
- CHRS 3
- VPV 0
- Target Price
- CHRS $4.68
- VPV N/A
- AVG Volume (30 Days)
- CHRS 1.3M
- VPV 36.6K
- Earning Date
- CHRS 08-07-2025
- VPV 01-01-0001
- Dividend Yield
- CHRS N/A
- VPV 3.60%
- EPS Growth
- CHRS N/A
- VPV N/A
- EPS
- CHRS N/A
- VPV N/A
- Revenue
- CHRS $272,251,000.00
- VPV N/A
- Revenue This Year
- CHRS N/A
- VPV N/A
- Revenue Next Year
- CHRS $106.56
- VPV N/A
- P/E Ratio
- CHRS N/A
- VPV N/A
- Revenue Growth
- CHRS 19.87
- VPV N/A
- 52 Week Low
- CHRS $0.66
- VPV $8.58
- 52 Week High
- CHRS $2.43
- VPV $10.28
- Technical
- Relative Strength Index (RSI)
- CHRS 56.33
- VPV 59.50
- Support Level
- CHRS $0.73
- VPV $9.82
- Resistance Level
- CHRS $0.82
- VPV $10.12
- Average True Range (ATR)
- CHRS 0.04
- VPV 0.10
- MACD
- CHRS 0.01
- VPV 0.02
- Stochastic Oscillator
- CHRS 99.23
- VPV 81.82
About CHRS Coherus BioSciences Inc.
Coherus Oncology Inc is a fully integrated commercial-stage inventive oncology company with an approved next-generation PD-1 inhibitor, LOQTORZI, and a pipeline that includes two mid-stage clinical candidates targeting liver, lung, head & neck, and other cancers. Its strategy is to expand the use of LOQTORZI in NPC and advance the development of new indications for LOQTORZI in combination with both its pipeline candidates as well as its industry partners, driving synergies from proprietary combinations, including first-in-class anticancer agents. Its portfolio includes LOQTORZI, CHS-114, and Casdozokitug.
About VPV Invesco Pennsylvania Value Municipal Income Trust (DE)
Invesco Pennsylvania Value Municipal Income Trust is a diversified, closed-end management investment company. The investment objective is to provide common shareholders with a high level of current income exempt from federal and Pennsylvania income taxes and, where possible under local law, local income and personal property taxes, consistent with preservation of capital.